News
Your browser does not support HTML5 video. 00:00 / 00:00 At the world’s largest insulin factory in Kalundborg, Denmark, the journey of a vial begins. Its content ...
Study design. This prospective, randomized, controlled, parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized ...
Novo Nordisk’s insulin brand Mixtard will continue to be available in vials, the Danish healthcare company clarified, even as it phases out its penfill. The penfill is being phased out as part ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results